Statera Biopharma (STAB) Competitors

NVN Liquidation (NASDAQ:NOVNQ) and Statera Biopharma (NASDAQ:STAB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation.

Which has more volatility and risk, NOVNQ or STAB?

NVN Liquidation has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Comparatively, Statera Biopharma has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500.

Is NOVNQ or STAB more profitable?

Company	Net Margins	Return on Equity	Return on Assets
NVN Liquidation	N/A	N/A	N/A
Statera Biopharma	N/A	N/A	N/A

Which has preferable valuation & earnings, NOVNQ or STAB?

NVN Liquidation has higher revenue and earnings than Statera Biopharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NVN Liquidation	$23.68M	0.00	-$31.31M	-$1.32	0.00
Statera Biopharma	$1.49M	0.03	-$101.85M	N/A	N/A

Do analysts prefer NOVNQ or STAB?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NVN Liquidation	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Statera Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community believe in NOVNQ or STAB?

NVN Liquidation and Statera Biopharma both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
NVN Liquidation	N/A	N/A
Statera Biopharma	N/A	N/A

Does the media prefer NOVNQ or STAB?

In the previous week, Statera Biopharma had 1 more articles in the media than NVN Liquidation. MarketBeat recorded 1 mentions for Statera Biopharma and 0 mentions for NVN Liquidation. Statera Biopharma's average media sentiment score of 0.00 equaled NVN Liquidation'saverage media sentiment score.

Company	Overall Sentiment
NVN Liquidation	Neutral
Statera Biopharma	Neutral

Summary

NVN Liquidation beats Statera Biopharma on 3 of the 5 factors compared between the two stocks.